HUM Stock Analysis: Buy, Sell, or Hold?
HUM - Humana Inc.
$359.13
-1.59 (-0.44%)
▼
5d:
-5.56%
30d:
+18.26%
90d:
+111.08%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Smart Money Distribution
None View Scanner →
Strength: 6.0/10
Get Alerted When HUM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HUM trades at premium valuation expecting 10.6% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: HUM trades at premium valuation expecting 10.6% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$517.79
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$321.51
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HUM is currently trading at $359.13, which is considered slightly high relative to its 30-day fair value range of $306.37 to $363.02. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.9) compared to its historical average (16.9). At these levels, the market is pricing in 10.6% annual earnings growth.
Technical Outlook: Technically, HUM is in a strong uptrend. The price is approaching resistance at $365.22. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $301.62. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HUM is in a strong uptrend. The price is approaching resistance at $365.22. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $301.62. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$306.37 -
$363.02
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.0%
Protect Your Profits
Holding HUM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 16.4% above Wall St target ($301.62)
- BULLISH: Expecting earnings turnaround to 10.6% growth with 23.5% revenue growth
- CAUTION: 5-day price weakness (-5.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$306.37 -
$363.02
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$302.04
Resistance Level
$365.22
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.93
Wall Street Target
$301.63
(-16.4%)
Revenue Growth (YoY)
23.5%
Earnings Growth (YoY)
-4.6%
Profit Margin
0.8%
Valuation Premium vs History
+10.6% premium
PE vs Historical
22.9 vs 16.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.6%
(market-implied from PE analysis)
1-Year Target
$398.96
(+11%)
2-Year Target
$441.25
(+22%)
3-Year Target
$488.02
(+35%)
3-Yr Target (if PE normalizes)
(PE: 23→17)
PE COMPRESSION
$359.73
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.9, Growth: 77.9%)
$1217.43
(+238%)
Base:
(SPY PE: 21.8, Growth: 77.9%)
$1156.52
(+221%)
Bear:
(PE: 16.9, Growth: 77.9%)
$897.39
(+149%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 38.45 | Current EPS (TTM): $9.38
Bull Case
$665.42
(+85%)
Analyst growth 67.7%, PE expands to 42.3
Base Case
$604.93
(+68%)
Market implied 67.7%, PE stable at 38.5
Bear Case
$245.24
(-32%)
Severe decline -20.0%, PE contracts to 32.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 4:18 PM ET
Data refreshes hourly during market hours. Next update: 5:18 PM
Data refreshes hourly during market hours. Next update: 5:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HUM showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ro Khanna
BUY
2026-03-23
Ro Khanna
SELL
2026-02-24
Sanjay K Shetty
BUY
810 shares
2026-02-23
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$105 | 64 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$410 | 55 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 55 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$416 | 58 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$61 | 59 HOLD |
Advanced HUM Option Strategies
Professional options setups generated by AI based on today's HUM price and gamma walls.
